| scholarly article | Q13442814 |
| P356 | DOI | 10.1212/WNL.0B013E3181A41269 |
| P698 | PubMed publication ID | 19414726 |
| P50 | author | Delphine Magis | Q30347438 |
| Gianluca Coppola | Q44744683 | ||
| Cherubino Di Lorenzo | Q57008411 | ||
| Filippo Maria Santorelli | Q60541206 | ||
| P2093 | author name string | C Rengo | |
| J Schoenen | |||
| F Pierelli | |||
| G S Grieco | |||
| C Casali | |||
| M Bolla | |||
| M Ciccolella | |||
| P2860 | cites work | Clinical expression of Leber hereditary optic neuropathy is affected by the mitochondrial DNA-haplogroup background | Q24678122 |
| P433 | issue | 18 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | mitochondrial DNA | Q27075 |
| riboflavin | Q130365 | ||
| P1104 | number of pages | 7 | |
| P304 | page(s) | 1588-1594 | |
| P577 | publication date | 2009-05-01 | |
| P1433 | published in | Neurology | Q1161692 |
| P1476 | title | Mitochondrial DNA haplogroups influence the therapeutic response to riboflavin in migraineurs | |
| P478 | volume | 72 |
| Q49073549 | 31P-MRS demonstrates a reduction in high-energy phosphates in the occipital lobe of migraine without aura patients |
| Q92956529 | A ketogenic diet normalizes interictal cortical but not subcortical responsivity in migraineurs |
| Q34166923 | Alternative headache treatments: nutraceuticals, behavioral and physical treatments |
| Q37778476 | Beyond the serotonin hypothesis: Mitochondria, inflammation and neurodegeneration in major depression and affective spectrum disorders |
| Q90243415 | CALCA and TRPV1 genes polymorphisms are related to a good outcome in female chronic migraine patients treated with OnabotulinumtoxinA |
| Q34303464 | CoEnzyme Q10 and riboflavin: the mitochondrial connection |
| Q36952254 | Cortical functional correlates of responsiveness to short-lasting preventive intervention with ketogenic diet in migraine: a multimodal evoked potentials study. |
| Q36506108 | Cyclic vomiting syndrome versus inborn errors of metabolism: A review with clinical recommendations |
| Q57985150 | Diet and nutraceutical interventions for headache management: A review of the evidence |
| Q37632904 | Diet transiently improves migraine in two twin sisters: possible role of ketogenesis? |
| Q47160332 | Dietary Reference Values for riboflavin |
| Q46322546 | Effectiveness of coenzyme Q10 in prophylactic treatment of migraine headache: an open-label, add-on, controlled trial |
| Q38265493 | Effectiveness of riboflavin in pediatric migraine prevention |
| Q40780781 | Evidences of Reduced Antioxidant Activity in Patients With Chronic Migraine and Medication-Overuse Headache. |
| Q54418514 | High frequency of migraine-only patients negative for the 3243 A>G tRNALeu mtDNA mutation in two MELAS families. |
| Q34473830 | Improvement of migraine symptoms with a proprietary supplement containing riboflavin, magnesium and Q10: a randomized, placebo-controlled, double-blind, multicenter trial |
| Q34327086 | Magnetic resonance spectroscopy in migraine: what have we learned so far? |
| Q34145598 | Medium-dose riboflavin as a prophylactic agent in children with migraine: a preliminary placebo-controlled, randomised, double-blind, cross-over trial |
| Q36210660 | Migraine and genetic polymorphisms: an overview |
| Q27010458 | Migraine headache: a review of the molecular genetics of a common disorder |
| Q51118095 | Migraine improvement during short lasting ketogenesis: a proof-of-concept study. |
| Q92276961 | Mitochondria in migraine pathophysiology - does epigenetics play a role? |
| Q37618225 | Mitochondrial gene profiling: translational perspectives |
| Q28686919 | Mitochondrial genetic background modifies the relationship between traffic-related air pollution exposure and systemic biomarkers of inflammation |
| Q52332599 | Non-Pharmacological Approaches for Migraine. |
| Q35938798 | Nutraceuticals in Acute and Prophylactic Treatment of Migraine |
| Q38180106 | Nutraceuticals in the prophylaxis of pediatric migraine: Evidence-based review and recommendations |
| Q38195629 | Pharmacogenomics of episodic migraine: time has come for a step forward. |
| Q39239760 | Pharmacokinetic Variability of Drugs Used for Prophylactic Treatment of Migraine |
| Q34117168 | Potential therapeutic benefits of strategies directed to mitochondria. |
| Q37191145 | Prevalence and risk of migraine headaches in adult fragile X premutation carriers |
| Q47594541 | Prevalence of Headache in Patients With Mitochondrial Disease: A Cross-Sectional Study |
| Q41264683 | Prevalence of migraine in persons with the 3243A>G mutation in mitochondrial DNA. |
| Q55171708 | Prophylactic effect of riboflavin on pediatric migraine: a randomized, double-blind, placebo-controlled trial. |
| Q38796523 | Prophylaxis of migraine headaches with riboflavin: A systematic review |
| Q48761835 | Riboflavin and migraine: the bridge over troubled mitochondria |
| Q48969987 | Riboflavin in cyclic vomiting syndrome: efficacy in three children |
| Q90497079 | The metabolic face of migraine - from pathophysiology to treatment |
| Q38105147 | The pathophysiological and pharmacological basis of current drug treatment of migraine headache |
| Q97523249 | Therapeutic Implications of Altered Energy Metabolism in Migraine: A State-of-the-Art Review |
| Q36240932 | Visual evoked potentials in subgroups of migraine with aura patients |
| Q45866600 | Efficacité de la riboflavine dans la prévention de la migraine pédiatrique |
Search more.